BNP Paribas Financial Markets
SIOX

BNP Paribas Financial Markets’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

BNP Paribas Financial Markets’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed -$5 – 4243
2020
Q3 		$5 Hold
1
– – ﹤0.01% 4189
2020
Q2 		$3 Sell
1
-10
-91% -$32 ﹤0.01% 4291
2020
Q1 		$27 Hold
11
– – ﹤0.01% 4264
2019
Q4 		$56 Sell
11
-66
-86% -$366 ﹤0.01% 4357
2019
Q3 		$497 Hold
77
– – ﹤0.01% 4420
2019
Q2 		$480 Sell
77
-2
-3% -$15 ﹤0.01% 4407
2019
Q1 		$838 Sell
79
-132
-63% -$1.31K ﹤0.01% 4158
2018
Q4 		$1.68K Buy
211
+23
+12% +$332 ﹤0.01% 3828
2018
Q3 		$3.63K Hold
188
– – ﹤0.01% 4158
2018
Q2 		$3.39K Sell
188
-676
-78% -$9.97K ﹤0.01% 4188
2018
Q1 		$9.19K Buy
864
+30
+4% +$482 ﹤0.01% 4021
2017
Q4 		$35.2K Buy
834
+446
+115% +$20K ﹤0.01% 3823
2017
Q3 		$21.3K Sell
388
-20
-5% -$3.37K ﹤0.01% 3563
2017
Q2 		$75.8K Buy
408
+388
+1,940% +$68K ﹤0.01% 2966
2017
Q1 		$2.33K Sell
20
-32
-62% -$3.35K ﹤0.01% 3504
2016
Q4 		$5.18K Sell
52
-157
-75% -$16.5K ﹤0.01% 3697
2016
Q3 		$23.4K Buy
209
+89
+74% +$10.7K ﹤0.01% 2799
2016
Q2 		$12.3K Buy
+120
New +$12K ﹤0.01% 2807
2016
Q1 		– Sell
-304
Closed -$43.9K – 3188
2015
Q4 		$43.9K Sell
304
-24
-7% -$3.12K ﹤0.01% 2902
2015
Q3 		$33.9K Buy
+328
New +$38.5K ﹤0.01% 3111

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

BNP Paribas Financial Markets's SIOX Position: Q4 2020 in Review

BNP Paribas Financial Markets sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2020, closing a stake of 1 share — an estimated $5 sold.

BNP Paribas Financial Markets first reported a position in SIOX in Q3 2015 and held it in 20 quarters. The position peaked at $75.8K in Q2 2017. 62 funds tracked by Wall St. Rank hold SIOX as of Q4 2020.

  • BNP Paribas Financial Markets reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1 Sio Gene Therapies Inc. Common Stock share in Q4 2020, an estimated $5.
  • BNP Paribas Financial Markets first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 20 quarters.
  • BNP Paribas Financial Markets's Sio Gene Therapies Inc. Common Stock position peaked at $75.8K in Q2 2017.
  • 62 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.